Sale of 28,837 shares at $7.13 per share.
Reporting Persons MPM BioVentures 2014, L.P. · EVNIN LUKE · GADICKE ANSBERT · Foley Todd · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · Transaction Code S
Traded Sep 9, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0001231919-26-001155 · filed 2026-09-09 · View filing →
Sale of 28,837 shares at $7.13 per share.
Reporting Persons MPM BIOVENTURES 2018, L.P. · MPM BioVentures 2018 LLC · MPM BioVentures 2018 GP LLC · Transaction Code S
Traded Sep 9, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0001231919-26-001156 · filed 2026-09-09 · View filing →
Sale of 192,500 shares at $7.41 per share.
Reporting Persons MPM BioVentures 2014, L.P. · EVNIN LUKE · GADICKE ANSBERT · Foley Todd · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0001231919-26-001155 · filed 2026-09-09 · View filing →
Sale of 192,500 shares at $7.41 per share.
Reporting Persons MPM BIOVENTURES 2018, L.P. · MPM BioVentures 2018 LLC · MPM BioVentures 2018 GP LLC · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0001231919-26-001156 · filed 2026-09-09 · View filing →
Sale of 38,500 shares at $7.11 per share.
Reporting Persons MPM BioVentures 2014, L.P. · EVNIN LUKE · GADICKE ANSBERT · Foley Todd · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0001231919-26-001155 · filed 2026-09-09 · View filing →
Sale of 38,500 shares at $7.11 per share.
Reporting Persons MPM BIOVENTURES 2018, L.P. · MPM BioVentures 2018 LLC · MPM BioVentures 2018 GP LLC · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0001231919-26-001156 · filed 2026-09-09 · View filing →
Sale of 32,263 shares at $7.17 per share.
Reporting Persons MPM BioVentures 2014, L.P. · EVNIN LUKE · GADICKE ANSBERT · Foley Todd · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · Transaction Code S
Traded Sep 3, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001231919-26-001143 · filed 2026-09-03 · View filing →
Sale of 32,263 shares at $7.17 per share.
Reporting Persons MPM BIOVENTURES 2018, L.P. · MPM BioVentures 2018 LLC · MPM BioVentures 2018 GP LLC · Transaction Code S
Traded Sep 3, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001231919-26-001144 · filed 2026-09-03 · View filing →
Sale of 25,131 shares at $7.19 per share.
Reporting Persons MPM BioVentures 2014, L.P. · EVNIN LUKE · GADICKE ANSBERT · Foley Todd · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001231919-26-001143 · filed 2026-09-03 · View filing →
Sale of 25,131 shares at $7.19 per share.
Reporting Persons MPM BIOVENTURES 2018, L.P. · MPM BioVentures 2018 LLC · MPM BioVentures 2018 GP LLC · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001231919-26-001144 · filed 2026-09-03 · View filing →
Disposition (code F) of 8,724 shares at $7.1439 per share.
Reporting Person Doshi Dipal · Officer Title CEO · Transaction Code F
Traded Sep 2, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001613084-26-000004 · filed 2026-09-03 · View filing →
Disposition (code F) of 1,733 shares at $7.1439 per share.
Reporting Person WENTWORTH KORY JAMES · Officer Title Chief Financial Officer · Transaction Code F
Traded Sep 2, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001725663-26-000007 · filed 2026-09-03 · View filing →
Disposition (code F) of 2,528 shares at $7.1439 per share.
Reporting Person Dowden Nathan J · Officer Title President & COO · Transaction Code F
Traded Sep 2, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001873392-26-000006 · filed 2026-09-03 · View filing →
Disposition (code F) of 2,079 shares at $7.1439 per share.
Reporting Person Sethuraman Natarajan · Officer Title President, Research & Develop. · Transaction Code F
Traded Sep 2, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001873394-26-000005 · filed 2026-09-03 · View filing →
Sale of 29,088 shares at $7.06 per share.
Reporting Persons MPM BioVentures 2014, L.P. · EVNIN LUKE · GADICKE ANSBERT · Foley Todd · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001231919-26-001143 · filed 2026-09-03 · View filing →
Sale of 29,088 shares at $7.06 per share.
Reporting Persons MPM BIOVENTURES 2018, L.P. · MPM BioVentures 2018 LLC · MPM BioVentures 2018 GP LLC · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001231919-26-001144 · filed 2026-09-03 · View filing →
Sale of 44,259 shares at $6.99 per share.
Reporting Persons MPM BioVentures 2014, L.P. · EVNIN LUKE · GADICKE ANSBERT · Foley Todd · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · Transaction Code S
Traded Aug 31, 2026 · Disclosed Aug 31, 2026
Source: SEC Form 4 · 0001231919-26-001135 · filed 2026-08-31 · View filing →
Sale of 44,259 shares at $6.99 per share.
Reporting Persons MPM BIOVENTURES 2018, L.P. · MPM BioVentures 2018 LLC · MPM BioVentures 2018 GP LLC · Transaction Code S
Traded Aug 31, 2026 · Disclosed Aug 31, 2026
Source: SEC Form 4 · 0001231919-26-001136 · filed 2026-08-31 · View filing →
Sale of 3,733 shares at $7.01 per share.
Reporting Persons MPM BioVentures 2014, L.P. · EVNIN LUKE · GADICKE ANSBERT · Foley Todd · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · Transaction Code S
Traded Aug 28, 2026 · Disclosed Aug 31, 2026
Source: SEC Form 4 · 0001231919-26-001135 · filed 2026-08-31 · View filing →
Sale of 3,733 shares at $7.01 per share.
Reporting Persons MPM BIOVENTURES 2018, L.P. · MPM BioVentures 2018 LLC · MPM BioVentures 2018 GP LLC · Transaction Code S
Traded Aug 28, 2026 · Disclosed Aug 31, 2026
Source: SEC Form 4 · 0001231919-26-001136 · filed 2026-08-31 · View filing →
Sale of 38,922 shares at $7.20 per share.
Reporting Persons MPM BioVentures 2014, L.P. · EVNIN LUKE · GADICKE ANSBERT · Foley Todd · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · Transaction Code S
Traded Aug 27, 2026 · Disclosed Aug 31, 2026
Source: SEC Form 4 · 0001231919-26-001135 · filed 2026-08-31 · View filing →
Sale of 38,922 shares at $7.20 per share.
Reporting Persons MPM BIOVENTURES 2018, L.P. · MPM BioVentures 2018 LLC · MPM BioVentures 2018 GP LLC · Transaction Code S
Traded Aug 27, 2026 · Disclosed Aug 31, 2026
Source: SEC Form 4 · 0001231919-26-001136 · filed 2026-08-31 · View filing →
Sale of 14,569 shares at $7.06 per share.
Reporting Persons MPM BIOVENTURES 2018, L.P. · MPM BioVentures 2018 LLC · MPM BioVentures 2018 GP LLC · Transaction Code S
Traded Aug 26, 2026 · Disclosed Aug 26, 2026
Source: SEC Form 4 · 0001231919-26-001106 · filed 2026-08-26 · View filing →
Sale of 14,569 shares at $7.06 per share.
Reporting Persons MPM BioVentures 2014, L.P. · EVNIN LUKE · GADICKE ANSBERT · Foley Todd · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · Transaction Code S
Traded Aug 26, 2026 · Disclosed Aug 26, 2026
Source: SEC Form 4 · 0001231919-26-001107 · filed 2026-08-26 · View filing →
Sale of 26,522 shares at $7.54 per share.
Reporting Persons MPM BIOVENTURES 2018, L.P. · MPM BioVentures 2018 LLC · MPM BioVentures 2018 GP LLC · Transaction Code S
Traded Aug 25, 2026 · Disclosed Aug 26, 2026
Source: SEC Form 4 · 0001231919-26-001106 · filed 2026-08-26 · View filing →
Sale of 26,522 shares at $7.54 per share.
Reporting Persons MPM BioVentures 2014, L.P. · EVNIN LUKE · GADICKE ANSBERT · Foley Todd · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · Transaction Code S
Traded Aug 25, 2026 · Disclosed Aug 26, 2026
Source: SEC Form 4 · 0001231919-26-001107 · filed 2026-08-26 · View filing →
Sale of 21,623 shares at $7.34 per share.
Reporting Persons MPM BIOVENTURES 2018, L.P. · MPM BioVentures 2018 LLC · MPM BioVentures 2018 GP LLC · Transaction Code S
Traded Aug 24, 2026 · Disclosed Aug 26, 2026
Source: SEC Form 4 · 0001231919-26-001106 · filed 2026-08-26 · View filing →
Sale of 21,623 shares at $7.34 per share.
Reporting Persons MPM BioVentures 2014, L.P. · EVNIN LUKE · GADICKE ANSBERT · Foley Todd · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · Transaction Code S
Traded Aug 24, 2026 · Disclosed Aug 26, 2026
Source: SEC Form 4 · 0001231919-26-001107 · filed 2026-08-26 · View filing →